The Oncology Institute, Inc. TOI Debt Repayments
Debt Repayments at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RepaymentsOfLongTermDebt.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s debt repayments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s debt repayments?
- The Oncology Institute, Inc. (TOI) reported debt repayments of $0 in Q1 2026.
- How has The Oncology Institute, Inc.'s debt repayments changed year-over-year?
- The Oncology Institute, Inc.'s debt repayments decreased by 100.0% year-over-year, from $20M to $0.
- What is the long-term trend for The Oncology Institute, Inc.'s debt repayments?
- Over 2 years (2021 to 2024), The Oncology Institute, Inc.'s debt repayments has grown at a -100.0% compound annual growth rate (CAGR), from $7.22M to $0.
- What does debt repayments mean?
- Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.